Category Archives: India

A ‘New’ Recipe for Trade

By Shalini Bhutani, The Economic & Political Weekly (Vol. 52 Issue No. 7) With other mega regional trade agreements like the Trans–Pacific Partnership in uncertainty, trade treaties like the Regional Comprehensive Economic Partnership will acquire greater significance beyond their original … Continue reading

Posted in IPR policy, Regional Comprehensive Economic Partnership, TPP, Transatlantic Trade and Investment Partnership (TTIP), TRIPS plus, Uncategorized | Leave a comment

Indian pharma at odds with US trade group over USTR Priority Watch List

The tug of war continues. Even as the Indian Pharmaceutical Alliance, the domestic drug industry lobby group, has appealed to the US Trade Representative to remove India from its Priority Watch List – the latter includes countries that are alleged … Continue reading

Posted in IP Rights, IPR, IPR policy, Special 301 report, Uncategorized, USTR 301 report | Leave a comment

Patent denied, price of prostate cancer drug may go down

The Indian Patent Office recently denied a patent for the drug Xtandi (Enzalutamide) by Japanese firm Astellas Pharma used in  treatment of prostate cancer. This decision comes in the light of the pre-grant opposition filed by pharma companies BDR Pharma, drug … Continue reading

Posted in Bayh Dole Act, March in rights, Patent, Patent Opposition, Sec 3 (d), Uncategorized | Tagged | Leave a comment

India to US: Will not tighten IPR rules beyond TRIPS mandate

Commerce Minister Nirmala Sitharaman demands food safety clearance mechanism during talks with US Trade Representative Source: The Hindu BusinessLine | October 20, 2016 India and the US continued to differ on the issue of intellectual property rights (IPR) norms at … Continue reading

Posted in Compulsory Licensing, Data Exclusivity, Evergreening, IPR, Patent linkage, Sec 3 (d), TRIPS, TRIPS plus, Uncategorized, UNHLP report, USTR 301 report | Leave a comment

Our view on India and US Joint Statement on the Trade Policy Forum Delhi – October 20, 2016

In the recently concluded US India Trade Policy Forum meeting held in Delhi, both countries laid emphasis on the importance of having a robust and balanced IPR protection in fostering creativity, promoting innovation, and attracting investment. Indian government was praised … Continue reading

Posted in IPR, IPR policy, TRIPS plus, Uncategorized | Leave a comment

US wants India to do ‘a lot more’ to tighten IPR regime

Source: Deccan Herald | August 30, 2016 The US on Monday prodded India to do “a lot more” to strengthen the Intellectual Property Rights regime to help not only the foreign investors, but also domestic innovators.

Posted in IPR, IPR policy, Uncategorized | Leave a comment

Swamy & Subramanian: Comment and context

In a series of tweets, Swamy alleged that “Arvind Subramanian of Washington DC” had urged the US to act against India’s national interests, and called for him to be sacked. Source: The Indian Express | June 23, 2016 After having … Continue reading

Posted in Sec 3 (d), Uncategorized, USTR 301 report | Leave a comment